Literature DB >> 16847772

Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors.

Mitchell T Wallin1, Jeffrey A Wilken, Robert Kane.   

Abstract

Up to 70% of multiple sclerosis (MS) patients experience cognitive dysfunction during the course of their disease. The most often affected domains are attention, memory, and information processing speed. Sequelae of cognitive dysfunction include negative effects on activities of daily living, employment, and relationships. This article reviews cognitive dysfunction in MS and focuses specifically on assessment, imaging, and risk factors. A number of neuropsychological batteries have been developed specifically for assessing cognitive dysfunction in MS patients. Trade-offs in length, administrative support, and efficiency exist between the various batteries. Modern imaging techniques provide a clearer picture of MS-related damage to the central nervous system, which is the major cause of cognitive dysfunction. Additionally, candidate risk factors have been identified that may help predict which patients will develop cognitive dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16847772     DOI: 10.1682/jrrd.2004.09.0120

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  14 in total

1.  Cognitive Impairment in Multiple Sclerosis: Historical Aspects, Current Status, and Beyond.

Authors:  Serkan Özakbaş
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

2.  Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2010-03-05       Impact factor: 6.312

Review 3.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

4.  The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis.

Authors:  Pinar Yigit; Ayla Acikgoz; Zaur Mehdiyev; Ayfer Dayi; Serkan Ozakbas
Journal:  Ir J Med Sci       Date:  2020-10-01       Impact factor: 1.568

Review 5.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

6.  Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis.

Authors:  Sue-Jin Lin; Irene Vavasour; Brenda Kosaka; David K B Li; Anthony Traboulsee; Alex MacKay; Martin J McKeown
Journal:  Hum Brain Mapp       Date:  2018-09-21       Impact factor: 5.038

7.  Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain.

Authors:  Andrew J Kwilasz; Suzanne M Green Fulgham; Julissa Chante Duran-Malle; Anouk E W Schrama; Eric H Mitten; Laurel S Todd; Hardik P Patel; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Lewis O Harvey; Steven F Maier; Raymond A Chavez; Kenner C Rice; Anne-Marie Van Dam; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2021-01-07       Impact factor: 7.217

Review 8.  The neurocognitive profile of the cerebellum in multiple sclerosis.

Authors:  Alessia Sarica; Antonio Cerasa; Aldo Quattrone
Journal:  Int J Mol Sci       Date:  2015-05-28       Impact factor: 5.923

9.  Restless Legs Syndrome in Multiple Sclerosis.

Authors:  Taşkın Güneş; Ufuk Emre; Yüksel Erdal; Osman Özgür Yalin
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

10.  Cognitive impairment in multiple sclerosis: a forgotten disability remembered.

Authors:  Kristen Rahn; Barbara Slusher; Adam Kaplin
Journal:  Cerebrum       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.